Gene Expression-Based Prediction of Myeloma Cell Sensitivity to Histone Deacetylase Inhibitors

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2013.392
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Histone Deacetylase Inhibitors in Multiple Myeloma

Hematology Reports
Hematology
2009English

Inhibitors of Histone-Deacetylase

Journal of Applied Biomedicine
GeneticsMolecular BiologyPharmacologyBiochemistryBiological SciencesToxicologyMedicineAgriculturalNeurosciencePharmaceutics
2005English

Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

New Insights Into the Treatment of Multiple Myeloma With Histone Deacetylase Inhibitors

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2012English

Manipulation of B-Cell Responses With Histone Deacetylase Inhibitors

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2015English

Pharmacogenomics and Histone Deacetylase Inhibitors

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2016English

Histone Deacetylase Inhibitor Downregulation of BCL-Xl Gene Expression Leads to Apoptotic Cell Death in Mesothelioma

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2001English

Histone Deacetylase Inhibitors From Burkholderia Thailandensis

Journal of Natural Products
Organic ChemistryMolecular MedicinePharmacologyComplementaryPharmaceutical ScienceAnalytical ChemistryAlternative MedicineDrug Discovery
2011English

Histone Deacetylase Inhibitors as Cancer Therapeutics

Annals of Translational Medicine
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy